2025-04-04 07:59:14
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Trigyn Technologies Ltd posts jump in Q3FY23 consolidated PAT to Rs. 15.33 crores
Posted On : 2023-02-12 15:53:04( TIMEZONE : IST )
Trigyn Technologies Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 342.2478 crores during the period ended December 31, 2022 as compared to Rs. 324.9118 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 15.3396 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 10.8059 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 4.98 for the period ended December 31, 2022 as compared to Rs. 3.51 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹342.2478 crs | ₹324.9118 crs |  5.34% |
| Net Profit | ₹15.3396 crs | ₹10.8059 crs | 41.96% |
| EPS | ₹4.98 | ₹3.51 | 41.88% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.342.2478 crores during the period ended December 31, 2022 as compared to Rs.262.1436 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.15.3396 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.9.2814 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.4.98 for the period ended December 31, 2022 as compared to Rs.3 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹342.2478 crs | ₹262.1436 crs | 30.56% |
| Net Profit | ₹15.3396 crs | ₹9.2814 crs | 65.27% |
| EPS | ₹4.98 | ₹3 | 66.00% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.952.9478 crores during the 9 Months period ended December 31, 2022 as compared to Rs.768.6490 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.32.0838 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.35.3602 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.10.42 for the 9 Months period ended December 31, 2022 as compared to Rs.11.43 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹952.9478 crs | ₹768.6490 crs | 23.98% |
| Net Profit | ₹32.0838 crs | ₹35.3602 crs |  -9.27% |
| EPS | ₹10.42 | ₹11.43 | -8.84% |
Shares of Trigyn Technologies Limited was last trading in BSE at Rs. 92.55 as compared to the previous close of Rs. 91.30. The total number of shares traded during the day was 7828 in over 322 trades.
The stock hit an intraday high of Rs. 92.90 and intraday low of 91.10. The net turnover during the day was Rs. 721802.00.
